Supplemental Figure S2 from A let-7 microRNA-Binding Site Polymorphism in KRAS Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/Panitumumab Monotherapy

Autor: Sabine Tejpar, Hubert Piessevaux, Olivier Bouché, Camilla Pilati, Dongyun Yang, Wu Zhang, David W. Salzman, Wendy De Roock, Jef De Schutter, Bart Jacobs, Pierre Laurent-Puig, Heinz-Josef Lenz, Joanne B. Weidhaas, Zenia Saridaki
Rok vydání: 2023
DOI: 10.1158/1078-0432.22454787
Popis: (A) Median progression-free survival according to type of therapy in the KRAS and BRAF mutated KRAS 3'-UTR LCS6 SNP carriers, (B) Median progression-free survival according to type of therapy in the KRAS and BRAF mutated non-KRAS 3'-UTR LCS6 SNP carriers, (C) Median overall survival according to type of therapy in the KRAS and BRAF mutated KRAS 3'-UTR LCS6 SNP carriers, (D) Median overall survival according to type of therapy in the KRAS and BRAF mutated non-KRAS 3'-UTR LCS6 SNP carriers.
Databáze: OpenAIRE